We therefore conclude that Mb is de novo expressed in breast cancer cells, although rare cases of so-called metaplastic carcinomas of the breast might exist in which Mb positivity stems from the rabdomyogenous differentiation of the cells (Jamieson and Rudland, 1990; Yang et al, 2003). Here, MB is linked to breast carcinoma.